Anti-TRIM21 antibodies isolated from patients with SS sterically hinder the interaction between TRIM21 and E2 ubiquitin-conjugating enzymes, thereby blocking TRIM21’s RING domain–dependent self-ubiquitination (113). Here, TRIM21 is linked to synovial sarcoma.